American National Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced were not tested for pH or platelet yield.
Recall ended Oct 5, 2026. Still check yours.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
The American National Red Cross recalled Apheresis Platelets, PAS, Leukocytes Reduced on July 16, 2026, because the products were not tested for pH or platelet yield. The FDA added the recall to its Enforcement Report and classified it on October 5, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these product details with yours, then check the recall notice for any restrictions.
Apheresis Platelets, PAS, Leukocytes Reduced
- Affected units
- W18422583103000V (double collection); W18422683327400G (double collection)
Details
- Company began the recall
- Event ID
- 100018
- Company
- The American National Red Cross
- Hazard
- Failed specifications
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
Summary updated
In FDA's weekly enforcement report
